Published in Health Business Week, April 30th, 2004
Net loss was $1,724,227 ($0.11 per share) in 2003 compared to net income of $278,541 ($0.02 per share) for the year 2002.
"The 2003 results reflected the longer than expected turnaround of the six centers we acquired and started-up," stated M. Lee Hulsebus, Miracor's CEO. "For 2004 we will continue to concentrate on revenue growth and capital needs; however, our main focus will be on returning Miracor to profitability."
Miracor opened its 15th diagnostic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.